Home NDC 72888-040-01 Spironolactone and hydrochlorothiazide
Product NDC 72888-040
Requested package NDC 72888-040-01
11-digit product format 728880040
Labeler code 72888
Product ID 72888-040_5b333a2a-14ce-8106-e063-6394a90aff6c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Spironolactone and hydrochlorothiazide
Dosage form TABLET
Route ORAL
Labeler Advagen Pharma Ltd.
Application ANDA220884
Marketing category ANDA
Marketing start 2026-09-10
Substance SPIRONOLACTONE; HYDROCHLOROTHIAZIDE
Active strength 25; 25 mg/1; mg/1
Pharmacologic classes Aldosterone Antagonist [EPC], Aldosterone Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A220884-001 SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE; SPIRONOLACTONE 25MG;25MG TABLET / ORAL AB 2026-09-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A220884-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A220884-001 SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE 25MG;25MG TABLET / ORAL AB 2026-09-10 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A220884-001 SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE 25MG;25MG TABLET / ORAL AB 2026-09-10 c2088c7a36db…2026-09-14 22:38:34 2026-08 A220884-001 SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE 25MG;25MG TABLET / ORAL AB 2026-09-10 84e616aacf4f…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Spironolactone and hydrochlorothiazide
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength SPIRONOLACTONE 25 mg/1 HYDROCHLOROTHIAZIDE 25 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 27O7W4T232 Internal UNII lookup 0J48LPH2TH Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 198224 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 72888-040-01 72888004001 30 TABLET in 1 BOTTLE (72888-040-01) 30 tablet 2026-09-10 No No Current